Dr. Bart GYPEN
ActiveSummary
Dr. Bart GYPEN has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €701,114 and a net result of €138,962. Equity is shrinking by about 6.7% per year across the filed financial years. The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. Bart GYPEN
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, overbrenging naar tweetalig gebied Brussel Hoofdstad of Nederlands taalgebied bij eenvoudige beslissing bestuursorgaan met…” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “ARTIKEL 12, ten minste één bestuurder is arts” (deed in Dutch)1 more provision on this in the deed
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “ARTIKEL 11, medische dossiers overgedragen aan artsen” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Thursday of June at 19:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Algemene vergadering in vormen statutenwijziging, elk moment” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Ontbinding en sluiting vereffening in één akte mits WVV-voorwaarden, zaken persoonlijke levenssfeer patiënten en/of beroepsgeheim arts(en)” (deed in Dutch)